Nutraceutical Composition for Telomere Lengthening, Reduction of DNA Damage, and Reduction of UV-Induced Skin Aging
OwnerJacob Rosensteininventor
Life of this patent
Estimating the term…
Abstract
A nutraceutical composition for inhibiting telomere shortening, for countering oxidative damage to DNA caused by free radicals, and for reducing UV-induced skin aging, the composition comprising a step of combining, in at least one of a capsule, tablet, softgel, powder, or liquid form, 20 mcg-20 mg astaxanthin/day with at least one of 100-5,000 IU vitamin D/day, 1-100 mg zinc/day, 1-500 mg niacinamide/day, 1-1,000 IU vitamin E/day, 1 mcg-100 mg lycopene/day, 1 mcg-100 mg beta-carotene/day, 1 mcg-500 mcg selenium/day, 1 mcg-100 mg lutein/day, and 1 mcg-100 mg zeaxanthin/day.
Claims4
A nutraceutical composition for inhibiting telomere shortening, for countering oxidative damage to DNA caused by free radicals, and for reducing UV-induced skin aging, the composition comprising a combination of 20 mcg-20 mg astaxanthin/day and one or more of:
- 100-5,000 IU vitamin D/day,
- 1-100 mg zinc/day,
- 1-500 mg niacinamide/day,
- 1-1,000 IU vitamin E/day,
- 1 mcg-100 mg lycopene/day,
- 1 mcg-100 mg beta-carotene/day,
- 1 mcg-500 mcg selenium/day,
- 1 mcg-100 mg lutein/day, and
- 1 mcg-100 mg zeaxanthin/day.
A method for inhibiting telomere shortening, for countering oxidative damage to DNA caused by free radicals, and for reducing UV-induced skin aging, the method comprising combining 20 mcg-20 mg astaxanthin/day with one or more of:
- 100-5,000 IU vitamin D/day,
- 1-100 mg zinc/day,
- 1-500 mg niacinamide/day,
- 1-1,000 IU vitamin E/day,
- 1 mcg-100 mg lycopene/day,
- 1 mcg-100 mg beta-carotene/day,
- 1 mcg-500 mcg selenium/day,
- 1 mcg-100 mg lutein/day, and
- 1 mcg-100 mg zeaxanthin/day.
Dependencies are inferred from the claim text.